Global  

Theraclion: Half-year Results 2020

Business Wire Wednesday, 23 September 2020
MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE, PEA-PME eligible) (Paris:ALTHE), an innovative company specializing in the development of medical equipment for echotherapy treatment, notably for varicose veins, today announces its half-year results 2020. David Caumartin, CEO of Theraclion, commented: « We are seeing a resumption of SONOVEIN® treatments in most of the centres already installed since the lifting of containment in France and other
0
shares
ShareTweetSavePostSend
 

You Might Like